Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Stopped early
Conditions studied: Cancer
In brief
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to chronic graft-versus-host disease in patients who have undergone donor stem cell transplant. PURPOSE: This phase I trial is studying chronic graft-versus-host disease in patients who have undergone donor stem cell transplant.
Key facts
- Study ID
- NCT00957736
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 252
- Starts
- 2008-11-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2013-05-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vanderbilt-Ingram Cancer Center - Cool Springs — Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin — Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.